Department of Pharmacology & Toxicology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Department of Physiology, University of Toronto, Toronto, ON, M5S 1A8, Canada.
Mol Psychiatry. 2021 Jul;26(7):2929-2942. doi: 10.1038/s41380-020-00859-4. Epub 2020 Aug 17.
N-methyl-D-aspartate receptors (NMDARs) are required to shape activity-dependent connections in the developing and adult brain. Impaired NMDAR signalling through genetic or environmental insults causes a constellation of neurodevelopmental disorders that manifest as intellectual disability, epilepsy, autism, or schizophrenia. It is not clear whether the developmental impacts of NMDAR dysfunction can be overcome by interventions in adulthood. This question is paramount for neurodevelopmental disorders arising from mutations that occur in the GRIN genes, which encode NMDAR subunits, and the broader set of mutations that disrupt NMDAR function. We developed a mouse model where a congenital loss-of-function allele of Grin1 can be restored to wild type by gene editing with Cre recombinase. Rescue of NMDARs in adult mice yields surprisingly robust improvements in cognitive functions, including those that are refractory to treatment with current medications. These results suggest that neurodevelopmental disorders arising from NMDAR deficiency can be effectively treated in adults.
N-甲基-D-天冬氨酸受体(NMDARs)对于在发育中和成年期大脑中形成活动依赖性连接是必需的。通过遗传或环境损伤导致的 NMDAR 信号转导受损会引起一系列神经发育障碍,表现为智力障碍、癫痫、自闭症或精神分裂症。目前尚不清楚 NMDAR 功能障碍的发育影响是否可以通过成年期的干预来克服。对于源自 GRIN 基因(编码 NMDAR 亚基)突变或更广泛的破坏 NMDAR 功能的突变引起的神经发育障碍,这个问题至关重要。我们开发了一种小鼠模型,其中 Grin1 的先天性功能丧失等位基因可以通过 Cre 重组酶的基因编辑恢复为野生型。成年小鼠中 NMDAR 的挽救产生了令人惊讶的认知功能的显著改善,包括那些对当前药物治疗无反应的功能。这些结果表明,源自 NMDAR 缺乏的神经发育障碍可以在成年期得到有效治疗。